Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines.
about
Stringent doxycycline-dependent control of gene activities using an episomal one-vector system.Defining inhibitory neurone function in respiratory circuits: opportunities with optogenetics?Marking embryonic stem cells with a 2A self-cleaving peptide: a NKX2-5 emerald GFP BAC reporterGlutamatergic neuronal differentiation of mouse embryonic stem cells after transient expression of neurogenin 1 and treatment with BDNF and GDNF: in vitro and in vivo studies.Embryonic stem cells overexpressing Pitx2c engraft in infarcted myocardium and improve cardiac function.A library of mammalian effector modules for synthetic morphologyExpression of transgenes targeted to the Gt(ROSA)26Sor locus is orientation dependent.Proteomic shifts in embryonic stem cells with gene dose modifications suggest the presence of balancer proteins in protein regulatory networks.The CMV early enhancer/chicken beta actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors.Synthetic design of strong promotersGeneration of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame.Microporation is a valuable transfection method for gene expression in human adipose tissue-derived stem cellsA comparison of exogenous promoter activity at the ROSA26 locus using a ΦiC31 integrase mediated cassette exchange approach in mouse ES cellsTowards optimising the production of and expression from polycistronic vectors in embryonic stem cells.A novel dual-color reporter for identifying insulin-producing beta-cells and classifying heterogeneity of insulinoma cell linesUtility of dual-modality bioluminescence and MRI in monitoring stem cell survival and impact on post myocardial infarct remodelingReliable transgene-independent method for determining Sleeping Beauty transposon copy numbersGeneration of plasmid vectors expressing FLAG-tagged proteins under the regulation of human elongation factor-1α promoter using Gibson assembly.Excision of translesion synthesis errors orchestrates responses to helix-distorting DNA lesions.Reprogramming of pancreatic exocrine cells towards a beta (β) cell character using Pdx1, Ngn3 and MafABidirectional Promoter Engineering for Single Cell MicroRNA Sensors in Embryonic Stem Cells.Coexpression of vascular endothelial growth factor and interleukin-1 receptor antagonist for improved human islet survival and function.Genetic engineering of mouse embryonic stem cells by Nurr1 enhances differentiation and maturation into dopaminergic neurons.Functional analysis of various promoters in lentiviral vectors at different stages of in vitro differentiation of mouse embryonic stem cells.Derivation of extraembryonic endoderm stem (XEN) cells from mouse embryos and embryonic stem cells.Feline neural progenitor cells II: use of novel plasmid vector and hybrid promoter to drive expression of glial cell line-derived neurotrophic factor transgeneOrthotopic model of SHG-44 in the enhanced green fluorescent protein nude mouse.Different Effects of Regulatory Genes (tat, nef) of Human Immunodeficiency Virus Type 1 (HIV-1) on the Proliferation and Differentiation of Mouse Embryonic Stem Cells in vitro.Integrated approach to produce a recombinant, His-tagged human α-galactosidase A in mammalian cells.Embryonic stem cell-derived glial precursors as a vehicle for sulfamidase production in the MPS-IIIA mouse brain.Detection of calcium transients in embryonic stem cells and their differentiated progenyApplying a "double-feature" promoter to identify cardiomyocytes differentiated from human embryonic stem cells following transposon-based gene delivery.Improvement of reporter activity by IRES-mediated polycistronic reporter system.Improved cardiac function in infarcted mice after treatment with pluripotent embryonic stem cells.Roles of the Nanog protein in murine F9 embryonal carcinoma cells and their endoderm-differentiated counterparts.Differential control of retrovirus silencing in embryonic cells by proteasomal regulation of the ZFP809 retroviral repressor.Neural development by transplanted human embryonal carcinoma stem cells expressing green fluorescent protein.Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cellsComparison of HCMV IE and EF-1 promoters for the stable expression of beta-subunit of hexosaminidase in CHO cell lines.Use of the Ki67 promoter to label cell cycle entry in living cells.
P2860
Q24812741-9D5FA2E9-DA52-4435-B966-6CEFE3D5A2EBQ26826858-2D033DC1-7A11-442A-A1AF-FDAB89F51C38Q27300999-D609490F-5DB4-44F1-9E50-33A9C9D79379Q30487438-EA7FBFCD-445F-40F7-B1D3-AB3D54F04AD5Q30553039-176DDC23-0587-4A21-8F2D-8290ADB446FAQ30605157-4F6754CC-9879-4E04-B94A-A97966C6B126Q33267298-54CBF1D7-B5F4-44FD-B516-70DCC7CCE7CDQ33307526-CF123D96-510F-4E01-B956-BB1A70D01248Q33314424-3602B928-9173-4D39-947F-B5882416F98AQ33529580-ED41AF1E-BC6B-4C96-8D0F-061660642F1FQ33652132-CC781536-B308-4D19-A37B-068F309D0F14Q33713216-508F2D88-CBD5-4935-8777-E958836219A3Q33997134-5B5A5948-C18D-4E38-BDBA-A49D09F48462Q34034314-E9F58D54-C741-4912-B013-2B30F5E0D06EQ34243843-A5E1BCAB-AFA3-4742-A9E1-0BC9B8D52326Q34644744-4CF7D7A9-36D3-4320-B239-78A332657D79Q34692725-6C67A1A5-08CC-43A8-96E6-2D8BF8DBC359Q35162210-C7FE18D7-2C9D-4226-A037-8F68753D7A57Q35600545-9348E598-73D6-4258-A03E-6A4863BE19B6Q35778769-9445F9C8-1633-4DCE-B69A-3A6E5EDC700BQ36010593-DC98DC72-B3C7-4360-930E-D05B21A41AD3Q36852073-7DF471EC-173D-40BC-939F-E98C77BC8407Q37029659-27B98FFE-BD20-4F7F-9D4A-0FC60F06CD44Q37037834-9732E2A1-C1AE-434F-8DE9-640E1D83D3BCQ37590887-9EF3CA6B-B793-468B-B017-7E26308F0644Q39355264-989AD98E-009F-4C74-A42A-D1A5FD6B8316Q39367347-0F45A8BE-D34A-496A-A858-024E14C20048Q39526442-E5DE3F83-8999-4CEE-8697-BEB76FB6280AQ39535178-EDD5156F-72B6-4E0D-9515-3F847644F7C0Q39721480-C6133F3C-2914-45BF-A949-138975D7891EQ39846234-DEBB0626-70EA-43BB-8C70-FAE45F1F209DQ39856750-6E1F4A05-750B-48F5-BA58-71BC4A4F6254Q40014118-63FF8A41-3C6E-4BDD-8B7E-7FB8D4C8C323Q40227112-00F2EEF9-684F-4F50-B361-1034FF8CCD4EQ40268262-9075D753-A19E-4708-B01E-C290F151489BQ40367498-5E0FF67E-E19A-467A-9D80-4077BE73098CQ40369662-7CF0C8DA-BB1A-41EC-B82C-D23504F35262Q40756627-785CF3E4-7139-4B87-8099-5425D8E1CC74Q42155604-FC5ADB6A-B0E2-4A3E-8E1A-0A23208B23E0Q42540910-05E17269-2623-48CF-BF05-7ECC03F34986
P2860
Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2002
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Analysis of different promoter ...... use embryonic stem cell lines.
@en
Analysis of different promoter ...... use embryonic stem cell lines.
@nl
type
label
Analysis of different promoter ...... use embryonic stem cell lines.
@en
Analysis of different promoter ...... use embryonic stem cell lines.
@nl
prefLabel
Analysis of different promoter ...... use embryonic stem cell lines.
@en
Analysis of different promoter ...... use embryonic stem cell lines.
@nl
P2093
P2860
P1433
P1476
Analysis of different promoter ...... ouse embryonic stem cell lines
@en
P2093
Kai-C Sonntag
Kwang-Soo Kim
Lars Björklund
Sangmi Chung
Therese Andersson
P2860
P304
P356
10.1634/STEMCELLS.20-2-139
P50
P577
2002-01-01T00:00:00Z